SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart. (2019)

First Author: Lim VG
Attributed to:  Investigating the renal microvasculature in polycystic kidney disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jacbts.2018.10.002

PubMed Identifier: 30847415

Publication URI: http://europepmc.org/abstract/MED/30847415

Type: Journal Article/Review

Volume: 4

Parent Publication: JACC. Basic to translational science

Issue: 1

ISSN: 2452-302X